Introduction of Abirapro 500 mg Tablet
Abirapro 500 mg Tablet is a medication used together with steroid medicine prednisone or methylprednisolone to treat prostate cancer. Abirapro Tablet is usually used in adult men whose prostate cancer has spread to other parts of the body and who have not responded to other forms of treatment, such as chemotherapy. Abirapro 500 stops your body from making testosterone, which can slow the growth of prostate cancer. It is important to note that Abirapro 500 Tablet is not a cure for prostate cancer, it can be managed and the progression of the disease can be slowed.
Abirapro is not safe for use in women. It is not known if Abirapro Tablet is safe and effective in females or children
Abirapro Tablet is usually taken by mouth once a day on an empty stomach. Do not eat food 2 hours before and 1 hour after taking Abirapro 500 Tablet. Abirapro 500 common side effects of the medication may include fatigue, joint pain, hot flashes, and nausea. More serious side effects, such as liver damage and low blood pressure, may also occur. It is important to discuss the potential risks and benefits of treatment with your doctor before starting Abirapro.
It's important before taking Abirapro 500 Tablet to inform your doctor if you have any pre-existing disease like liver disease, lung disease, diabetes, adrenal or pituitary gland problems or if you are using any medications or vitamins, Herbal medicines, etc. Additionally, inform them if you are pregnant, planning to become pregnant, or breastfeeding. The use of effective birth control (contraception) by both males and females during treatment with Abirapro 500 Tablet for 3 weeks to avoid pregnancy. Regular monitoring of your blood glucose levels while on treatment.
Uses of Abirapro 500 mg Tablet
Prostate cancer: Abirapro 500 mg Tablet is used to treat prostate cancer, a type of cancer that occurs in the prostate, a gland of the male reproductive system. It is one of the most common cancers in men. Symptoms of prostate cancer include difficulty urinating, frequent urination, and pain or burning during urination.
Benefits of Abirapro 500 mg Tablet
Abirapro 500 Tablet decreases the production of testosterone in males. In this way, the cancer cells decrease or stop growing due to low testosterone levels in the body.
Abirapro Tablet can slow the growth of prostate cancer cells and reduce the size of tumours.
Abirapro Tablet can delay the need for other treatments such as chemotherapy or radiation therapy and prolong survival in people with advanced prostate cancer.
Side Effects of Abirapro 500 mg Tablet
Abirapro 500 mg Tablet may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects of Abirapro 500 mg Tablet
- Urinary tract infection
- Peripheral oedema
Common Side Effects of Abirapro 500 mg Tablet
- Cardiac failure
- Angina pectoris
- Atrial fibrillation
- Dyspepsia (indigestion)
- Alanine aminotransferase increased
- Joint pain
- Hot flashes
How to Use Abirapro 500 mg Tablet?
Abirapro 500 Tablet taken by mouth once a day on an empty stomach. Do not eat food 2 hours before and 1 hour after taking Abirapro 500. Swallow the tablet whole with a full glass of water. Do not crush, chew, or open the tablet. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.
How Abirapro 500 mg Tablet Works?
Abirapro is an androgen synthesis inhibitor. Abirapro 500 mg Tablet works by blocking the action of an enzyme called CYP17A1, which is involved in the production of testosterone in the body. By inhibiting the production of testosterone, a hormone that can stimulate the growth of prostate cancer cells.
Safety Advices Abirapro 500 mg Tablet
It is important to use caution when taking Abirapro Tablet if you have liver disease, as the dose of the medication may need to be adjusted. It is recommended to consult with your doctor about the appropriate use of this medication in your specific situation.
It is not recommended to breastfeed while taking Abirapro. Abirapro Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Abirapro 500, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
Abirapro 500 Tablet is safe to use in patients with kidney disease. No dose adjustment of Abirapro Tablet is recommended. If you experience any side effects please consult your doctor.
Abirapro 500 mg Tablet is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while taking Abirapro Tablet such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.
Use of Abirapro 500 Tablet may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Abirapro during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
It is generally not recommended to drink alcohol while taking Abirapro 500 Tablet. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
1. Zytiga, Abiraterone Acetate, Janssen-cilag (new Zealand) Ltd, [Date Of Revison 17 Nov 2022, Product Leaflet
2. Abiraterone Acetate, Food And Drug Administration Center For Drug Evaluation And Research , India, Available Form
3. Abiraterone Acetate Tablets, For Oral Use, Msn Laboratories Private Limited, India, Product Leaflet
4. Zytiga, (abiraterone Acetate) , Janssen Biotech, Inc.[last Updated September 2021], Available Form
5. Zytiga, (abiraterone Acetate) Tablets, Patheon Inc., Mississauga, Canada, Product Monograph